German ethics commission disparages routine PND (prenatal diagnostics):
This article was originally published in Clinica
Over the past two decades, prenatal diagnostics (PND) have become a routine procedure within the German health system. Dr Wolfgang Wodarg, the Social Democratic (SPD) speaker of the parliamentary "rights and ethics of modern medicine" commission believes that the rise could lead to genetic selection, particularly if in the future easily accessible DNA chips were to be made available. In 1976 the sickness funds agreed to reimburse PND and since then the number of procedures has risen from 1,796 in 1976 to 68,267 in 1997. Dr Wodarg acknowledges that the rise has come as a result of doctors' obligations to inform parents about cystic fibrosis and an increase in the demand for ultrasound scans by pregnant women. The problem is that if no ultrasound scan is carried out, then the doctor will not be able to claim reimbursement for assisting a pregnancy, as the sickness funds would say that he had not carried out the necessary procedures.
You may also be interested in...
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.